Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s AI-powered blood glucose prediction engine has received CE mark approval in Europe. The One Drop platform provides real-time glucose forecasting up to eight hours in advance for people with prediabetes, type 2 diabetes on oral medications or insulin regimens, and gestational diabetes. Clinical results support its use as a personalized self-management tool that empowers users to achieve better outcomes through data-driven insights and remote care features. Bayer has partnered with the company to expand into additional therapeutic areas including cardiovascular disease and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Informed Data Systems.